Experimental Alzheimer's drug improved cognition and behavior
BioWorld - 02-Feb-2021With positive results in phase 2b, simufilam to begin phase III in second half of 2021
Join the club for FREE to access the whole archive and other member benefits.
News Source for innovative medicines, companies behind therapeutic candidates
BioWorld is the news source of record for the biotechnology industry. BioWorld reports the breaking news — and provides key perspective — on hundreds of innovative medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.
BioWorld was launched as a magazine in 1990 by David Bunnell and Cynthia Robbins-Roth.
Visit website: https://www.bioworld.com/
Details last updated 04-Feb-2021
With positive results in phase 2b, simufilam to begin phase III in second half of 2021
Platform is designed to help pharmaceutical companies detect substances efficiently